0RKT fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Ryvu Therapeutics SA engages in the provision of products and solutions for the pharmaceutical and biotechnology industry. Its projects and services include contract chemistry services, biology services, integrated drug discovery, and comparative studies of biosimilar medicinal products. The company was founded by Boguslaw Sieczkowski and Pawel Przewiezlikowski in 2007 and is headquartered in Krakow, Poland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
0RKT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company